Parkman Healthcare Partners’s Pulmonx LUNG Stock Holding History

Parkman Healthcare Partners’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$841K	Sell	646,564 -109,072	-14%	-$150K	0.09%	73
2026 Q1	$975K	Buy	755,636 +27,855	+4%	+$46K	0.1%	84
2025 Q4	$1.61M	Buy	727,781 +227,119	+45%	+$427K	0.15%	86
2025 Q3	$811K	Sell	500,662 -104,367	-17%	-$218K	0.08%	87
2025 Q2	$1.57M	Sell	605,029 -6,846	-1%	-$27K	0.18%	82
2025 Q1	$4.12M	Buy	611,875 +404,022	+194%	+$2.86M	0.49%	58
2024 Q4	$1.41M	Buy	207,853 +1,409	+0.7%	+$9.28K	0.19%	81
2024 Q3	$1.71M	Buy	+206,444	New	+$1.49M	0.22%	80

Other funds holding LUNG

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ECM

ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Parkman Healthcare Partners's LUNG Position: Q2 2026 in Review

Parkman Healthcare Partners reduced its Pulmonx (LUNG) stake by 14% in Q2 2026, selling an estimated $150K and leaving 646,564 shares worth $841K. The position accounts for 0.09% of the portfolio, ranked #73.

Parkman Healthcare Partners first reported a position in LUNG in Q3 2024 and has held it in 8 quarters since. The position peaked at $4.12M in Q1 2025. 107 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

Parkman Healthcare Partners held 646,564 shares of Pulmonx worth $841K as of Q2 2026.
Parkman Healthcare Partners sold 109,072 Pulmonx shares in Q2 2026, an estimated $150K.
Pulmonx made up 0.09% of Parkman Healthcare Partners's portfolio in Q2 2026, its #73 holding.
Parkman Healthcare Partners first reported a position in Pulmonx in Q3 2024 and has held it in 8 quarters since.
Parkman Healthcare Partners's Pulmonx position peaked at $4.12M in Q1 2025.
107 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.